002603 Shijiazhuang Yiling Pharmaceutical
- 17.22
- +0.09+0.53%
Shijiazhuang Yiling Pharmaceutical News
Eling Pharmaceutical: Notice on Wholly Owned Subsidiary Formulation Products Obtaining U.S. FDA Approval Numbers
Eling Pharmaceutical: Announcement on the inclusion of the company\'s drugs in the “National Medical Insurance Catalogue” through negotiations
Eling Pharmaceutical: Notice on Acceptance of Clinical Trial Applications for Innovative Chemical Drug G201-Na Capsules
Eling Pharmaceutical: Announcement on the acceptance of the application for clinical trials of the new traditional Chinese medicine Lianhua Yuping granular drug
Eling Pharmaceutical: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Eling Pharmaceutical: 2024 Semi-Annual Financial Report
Shijiazhuang Yiling Pharmaceutical: Announcement regarding the receipt of the notice of acceptance of pharmaceutical registration application.
Shijiazhuang Yiling Pharmaceutical: Legal Opinion of Guofeng Law Firm Beijing on the First Extraordinary General Meeting of Shareholders of Shijiazhuang Yiling Pharmaceutical Co., Ltd. in 2024.
Shijiazhuang Yiling Pharmaceutical: Announcement of the resolution of the first extraordinary shareholders' meeting of Shijiazhuang Yiling Pharmaceutical in 2024.
Shijiazhuang Yiling Pharmaceutical: Announcement regarding the receipt of the notice of acceptance of pharmaceutical registration application.
Shijiazhuang Yiling Pharmaceutical: Notice of the First Extraordinary Shareholders' Meeting in 2024
Shijiazhuang Yiling Pharmaceutical: Announcement on amending the Company's Articles of Association.
Shijiazhuang Yiling Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Eling Pharmaceutical
Shijiazhuang Yiling Pharmaceutical: Legal Opinion of Beijing Guofeng Law Firm on the 2023 Annual General Meeting of Shareholders of Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Shijiazhuang Yiling Pharmaceutical: Internal Control Self-Assessment Report
Shijiazhuang Yiling Pharmaceutical: Announcement on the Appointment of the 2024 Financial and Internal Control Audit Institution
Shijiazhuang Yiling Pharmaceutical: Report of the Audit Committee of the Board of Directors of Eling Pharmaceutical on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Shijiazhuang Yiling Pharmaceutical: Eling Pharmaceutical's shareholder return plan for the next three years (2024-2026)
Shijiazhuang Yiling Pharmaceutical: Notice of Annual General Meeting of Shareholders
Shijiazhuang Yiling Pharmaceutical: Announcement on the death of an independent director of the company
Analysis
Price Target
No Data
No Data